Zakaria Hafidi

Dr. Zakaria Hafidi

Chemistry and Chemical Engineering, Chalmers University of Technology, Gothenburg, Västra Götaland, Sweden
orcid
Postdoc researcher

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Chemical Engineering Journal
Verified
Journal Article
Closed access
ZAZakaria Anfar
Zakaria Anfar
AFAbdellah Ait El Fakir
Abdellah Ait El Fakir
MZMohamed Zbair
Mohamed Zbair
Zakaria HafidiZakaria Hafidi
Zakaria Hafidi
abdallah AMEDLOUSabdallah AMEDLOUS
abdallah AMEDLOUS
NANoureddine El Alem
Noureddine El Alem

1 April 2021 in Surfaces and Interfaces
Verified
Journal Article
Closed access
BIBrahim El Ibrahimi
Brahim El Ibrahimi
ABAli Baddouh
Ali Baddouh
RORachid Oukhrib
Rachid Oukhrib
SISouad El Issami
Souad El Issami
Zakaria HafidiZakaria Hafidi
Zakaria Hafidi
LBLahcen Bazzi
Lahcen Bazzi

13 April 2021 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
SFSaad Fettach
Saad Fettach
FTFatima Zahra Thari
Fatima Zahra Thari
Zakaria HafidiZakaria Hafidi
Zakaria Hafidi
HTHamza Tachallait
Hamza Tachallait
KKKhalid Karrouchi
Khalid Karrouchi
MFMy El Abbes Faouzi
My El Abbes Faouzi
In the present study, a series of thiazolidine-2,4-diones derivatives (3a–3e) and (4a–4e) were synthesized and characterized by 1H NMR, 13C NMR and ESI-MS spectrometry. All compounds were screened for their α-glucosidase and α-amylase inhibitory activities. In vitro biological investigations revealed that most of compounds were active against α-glucosidase with IC50 values in the range of 43.85 ± 1.06 to 380.10 ± 1.02 µM, and α-amylase with IC50 in the range of 18.19 ± 0.11 to 208.10 ± 1.80 µM. Some of the tested compounds were found to be more potent inhibitors than the clinical drug Acarbose (IC50glucosidase = 97.12 ± 0.35 µM and IC50amylase = 2.97 ± 0.004 μM). The lead compounds were evaluated for their acute toxicity on Swiss mice and found to be completely non-toxic with LD > 2000 mg/kg BW. Furthermore, the Structure–activity relationship (SAR) and the binding interactions of all compounds with the active site of α-glucosidase and α-amylase were confirmed through molecular docking and stabilizing energy calculations. This study has identified the inhibitory potential a new class of synthesized thiazolidine-2,4-diones in controlling both hyperglycemia and type 2 diabetes mellitus. Furthermore, the theoretical binding mode of the target molecules was evaluated by molecular docking studies against the 3D Crystal Structure of human pancreatic α-amylase (PDB ID: 1B2Y) and α-glucosidase (PDB ID: 3W37) Communicated by Ramaswamy H. Sarma

25 November 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
LPLourdes Perez
Lourdes Perez
MGMaria Teresa Garcia
Maria Teresa Garcia
APAurora Pinazo
Aurora Pinazo
EPEdgar Pérez-Matas
Edgar Pérez-Matas
Zakaria HafidiZakaria Hafidi
Zakaria Hafidi
MPMARÍA ELENA Bautista Pérez
MARÍA ELENA Bautista Pérez
Cationic surfactants have great potential as drug vehicles and for use in gene therapy (cationic vesicles made from cationic surfactants can encapsulate RNA or DNA for cellular transfer). They can also be used as antimicrobial and antifungal agents to treat human infections. In an era of increasing antimicrobial resistance, the development of new biocompatible surfactants suitable for application as antimicrobial agents is of high interest. In this work, a library of amino acid-based surfactants was synthesized, characterized and tested for antimicrobial activity. The head group architecture (number and type of amino acids, density of cationic charge, ionic character) and the hydrophobic moiety (alkyl chain length and position of the hydrophobic group) were systematically modified, and the effect on the surfactant biological and aggregation behavior was studied. Thus, the pKa values, micellization process, antimicrobial efficiency and biodegradability were evaluated. The critical micelle concentration values of the surfactants depended on their hydrophobic character, but changes in the polar head as well as the position and length of the alkyl chain also significantly affected activity against some of the tested microorganisms. Moreover, biodegradability was closely related to the hydrophobic character of the surfactant and attachment of the alkyl chain to the polar head. The structure–activity relationships established here may open perspectives for the design of effective biodegradable antimicrobial materials that can overcome emerging resistance.

26 November 2019 in Catalysis Letters
Verified
Journal Article
Closed access
PDF file
Zakaria HafidiZakaria Hafidi
Zakaria Hafidi
MTMohamed Ait Taleb
Mohamed Ait Taleb
abdallah AMEDLOUSabdallah AMEDLOUS
abdallah AMEDLOUS
MAMohammed El Achouri
Mohammed El Achouri

26 December 2021 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
SFSaad Fettach
Saad Fettach
FTFatima Zahra Thari
Fatima Zahra Thari
Zakaria HafidiZakaria Hafidi
Zakaria Hafidi
KKKhalid Karrouchi
Khalid Karrouchi
KBKaoutar Bouathmany
Kaoutar Bouathmany
MFMy El Abbes Faouzi
My El Abbes Faouzi
In this work, three isoxazoline-thiazolidine-2,4-dione derivatives were synthesized and characterized by FT-IR, 1H-NMR, 13C-NMR and ESI-MS spectrometry. All compounds have been investigated for their α-amylase and α-glucosidase inhibitory activities. In vitro enzymatic evaluation revealed that all compounds were inhibitory potent against α-glucosidase with IC50 values varied from 40.67 ± 1.81 to 92.54 ± 0.43 µM, and α-amylase with IC50 in the range of 07.01 ± 0.02 to 75.10 ± 1.06 µM. One of the tested compounds were found to be more potent inhibitor compared to other compounds and standard drug Acarbose (IC50 glucosidase= 97.12 ± 0.35 µM and IC50 amylase= 2.97 ± 0.01 μM). All compounds were then evaluated for their acute toxicity in vivo and shown their safety at a high dose with LD > 2000mg/kg BW. A cell-based toxicity evaluation was performed to determine the safety of compounds on liver cells, using the MTT assay against HepG2 cells, and the results shown that all compounds have non-toxic impact against cell viability and proliferation compared to reference drug (Pioglitazone). Furthermore, the molecular homology analysis, SAR and the molecular binding properties of compound with the active site of α-amylase and α-glucosidase were confirmed through computational analysis. This study has identified the inhibitory potential of a new class of synthesized isoxazoline-thiazolidine-2,4-dione derivatives in controlling both hyperglycemia and type 2 diabetes mellitus without any hepatic toxicity. Communicated by Ramaswamy H. Sarma